Testicular germ cell tumors occur in three age groups. Seminomas and nonseminomas of adults, including mature teratomas, and the precursor carcinoma in situ (CIS) are aneuploid. This also holds true for yolk sac tumors of newborn and infants, while the mature teratomas of this age are diploid. In contrast, spermatocytic seminomas occurring in the elderly contain both diploid and polyploid cells. Aneuploidy has been associated with centrosome aberrations, sometimes related to overexpression of STK15. Aneuploidy of non-neoplastic germ cells has been demonstrated in the context of male infertility, a risk factor for the development of seminoma/nonseminoma. We investigated aneuploidy, centrosome aberrations and the role of STK15 in different types of testicular germ cell tumors as well as in normal and disturbed spermatogenesis. The aneuploid seminomas and nonseminomas tumors (including CIS) showed increased numbers of centrosomes, without STK15 amplification or overexpression. Four out of six infantile teratomas had normal centrosomes, the remaining two and an infantile yolk sac tumor showed a heterogeneous pattern of cells with normal or amplified centrosomes. Spermatocytic seminomas had two, four or eight centrosomes. Germ cells in seminiferous tubules with disturbed spermatogenesis shared both aneuploidy and centrosome abnormalities with seminomas/nonseminomas and showed a more intense STK15 staining than those with normal spermatogenesis and CIS. Therefore, aneuploidy of testicular germ cell tumors is associated with amplified centrosomes probably unrelated to STK15.
Introduction
Aneuploidy is the most frequent genomic aberration found in solid tumors and has been proposed as a crucial event in the development of many malignancies (for review, see Mitelman, 2000) . Recent studies have suggested a link between centrosome anomalies, chromosomal constitution and phenotype. Centrosomes are cellular structures composed of a pair of centrioles associated with the so-called pericentriolar material, of which pericentrin is an important component (Doxsey et al., 1994) . Centrosomes are essential for proper cellular polarity and a balanced distribution of chromosomes during mitosis and meiosis (for review, see Hinchcliffe and Sluder, 2001) . Centrioles start to duplicate at the late G1/early S phase of the cell cycle, and two functional centrosomes are formed during G2. Centrin as one constituent of the centrioles appears to be important in the proper segregation of centrioles during cell cycle, probably regulated by phosphorylation of a serine residue (Lutz et al., 2001) . Aberrant centrin phosphorylation has been observed in breast cancer with supernumerous centrosomes (Lingle et al., 1998) .
In vitro experiments proved the link between centrosome amplification induced by inactivation of P53 (Fukasawa et al., 1996; Meek, 2000) , and overexpression of the centrosome-associated serine/threonine kinase STK 15 (BTAK/Aurora2/AuroraA) (Zhou et al., 1998) and aneuploidy. The STK15 gene maps to the long arm of chromosome 20, band q13, and it is found to be amplified in primary tumors of the breast, ovary, colon, prostate, cervix and neuroblastoma, and various cell lines. Overexpression of STK15 has also been reported without gene amplification. Lack of centrosome duplication before mitosis results in polyploidy, while aneuploidy might result from the presence of multiple centrosome duplications during one cell cycle. The presence of abnormal centrosomes, that is, amplification/hypertrophy and a disturbed cellular distribution, has been observed in various aneuploid cancers of different histogenesis (Lingle et al., 1998; Weber et al., 1998; Ghadimi et al., 2000; Gustafson et al., 2000; Kuo et al., 2000; Pihan et al., 2001) .
Aneuploidy is characteristic for all testicular germ cell tumors of adolescents and adults (TGCTs), that is, seminomas and nonseminomas (Oosterhuis et al., 1989; Looijenga et al., 1991 Looijenga et al., , 2000 El-Naggar et al., 1992; Korn et al., 1996; Mostert et al., 1996; Ottesen et al., 1997; Summersgill et al., 1998 Summersgill et al., , 2001 Rosenberg et al., 1999) . This is also the case for their common precursor carcinoma in situ (CIS) (De Graaff et al., 1992; Looijenga et al., 1993 Looijenga et al., , 2000 Gillis et al., 1994; Van Echten-Arends et al., 1995; Faulkner et al., 2000; Summersgill et al., 2001) . While seminomas are composed of cells highly similar to CIS cells, the nonseminomas can be composed of embryonal carcinoma, yolk sac tumor, choriocarcinoma and teratoma (Mostofi and Sesterhenn, 1998) . Interestingly, gain of the long arm of chromosome 20 has been found in some TGCTs, including CIS (Rosenberg et al., 1999; Looijenga et al., 2000; Summersgill et al., 2001) . As a result of the consistent aneuploidy of TGCTs, polyploidization has been proposed as one of the initiating events in the formation of CIS, although the mechanisms involved are unknown. Based on this knowledge, attempts have been undertaken to detect CIS cells in semen of patients suspected for the presence of a TGCT (Clausen et al., 1991; Giwercman, 1992; Giwercman et al., 1993) . This has not been successful so far, because of the small amounts of CIS cells present, as well as the presence of aneuploid nonmalignant germ cells in testicular samples showing atrophy, even unrelated to the presence of a TGCT. The mechanisms behind this phenomenon have also not been explored so far.
In contrast to the histological diversity of TGCTs, the germ cell tumors of newborn and infants are either teratoma or yolk sac tumor (Scully, 1978) . Whereas the yolk sac tumors of newborn and infants are aneuploid, the infantile teratomas are diploid (Perlman et al., 1994 (Perlman et al., , 2000 Looijenga et al., 2000; Mostert et al., 2000) . Within the adult testis, a third entity of germ cell tumors is identified, the so-called spermatocytic seminoma (Scully, 1961; Rosai et al., 1969; Talerman, 1974; Mu¨ller et al., 1987; Dekker et al., 1992; Burke and Mostofi, 1993; Cummings et al., 1994; Eble, 1994) . These tumors have a separate pathogenesis from that of TGCTs, and most likely originate from a germ cell that is able to undergo partial meiosis (for review, see Stoop et al., 2001) . This is in agreement with the presence of small, intermediate and large cells, representing nuclei with a diploid, a tetraploid and a hypertetraploid DNA content Rosenberg et al., 1998) .
We investigated the presence of centrosome abnormalites and a possible role of STK15 in the pathogenesis of both diploid and aneuploid germ cell tumors of different etiology and histology. In addition, these parameters were studied in the context of the presence of aneuploid germ cells in testicular parenchyma with atrophic features, related and unrelated to TGCTs.
Materials and methods

Tissue samples and patients characteristics
Tumor specimens were collected between 1997 and 2000 in close collaboration with urologists and pathologists in the South-Western part of the Netherlands. Tissue samples were snap frozen directly after surgery. Whenever feasible, samples from tumorous and nontumorous parts of the specimen were taken. Patients underwent orchidectomy/resection for TGCTs (n ¼ 26), spermatocytic seminoma (n ¼ 3), Leydig cell tumors (n ¼ 4), B-cell non-Hodgkin's lymphoma of the testis (n ¼ 3), non-neoplastic reasons (n ¼ 2) or infantile germ cell tumors (n ¼ 7). Patients characteristics are given in Table 1 .
Enzyme-and immunohistochemistry
Sections of 5 mm were air-dried, fixed in acetone for 5 min, airdried, rinsed in phosphate-buffered saline (PBS), blocked with PBS containing 1% bovine serum albumin (BSA, Sigma Chemicals, Zwijndrecht, the Netherlands). Antibodies were diluted in 1% BSA in PBS, all incubations (primary and secondary antibodies) were made at room temperature for 1 h. Sections were incubated with anti-STK15 antibody (rabbit polyclonal, provided by S Sen, diluted 1 : 50), and/or a mouse monoclonal anti-centrin (clone 20H5, diluted 1 : 600, kindly provided by Dr JL. Salisbury, Department of Biochemistry and Molecular Biology, Myo Clinic, Rochesterm, MN, USA), or antipericentrin (rabbit polyclonal, Babco, Richmond, CA, USA, diluted 1 : 200). Slides were rinsed in PBS and incubated with the respective secondary antibody (FITC-conjugated swine anti-rabbit immunoglobulin, DAKO, Glostrup, Den mark, diluted 1 : 50) and/or Cy3-conjugated goat anti-mouse immunoglobulin G (Jackson Immuno Research Laboratories, Westgrove, PA, USA, diluted 1 : 100), rinsed, postfixed in 4% formaline and mounted in Vectashield (Vecta Laboratories, Burlingame, CA, USA) containing 0.1% DAPI. Double stainings for centrin and pericentrin were performed on selected cases and showed identical results. For demonstration of endogenous alkaline phosphatase, which specifically demonstrates the presence of CIS cells (Roelofs et al., 1999) , slides were incubated in 60 ml Tris-buffer (0.2 m, pH 8) containing 15 mg Fast Red and 15 mg naphtol-As-MXphosphate (Sigma Chemicals, Zwijndrecht, the Netherlands) for 5 min before fixation in formalin.
Fluorescent in situ hybridization (FISH)
An STK15-specific probe (BAG 3B23, kindly given to use by Dr S Sen) was used to check for amplifications of the gene (Zhou et al., 1998) . For ploidy analysis, centromere-specific probes for chromosomes 12 (pa12H8; (Looijenga et al., 1990) (Higgens et al., 1985) ) were used. FISH was performed as previously described (Kersemaekers et al., 2002) .
Evaluation of immunohistochemical stainings, scoring of spermatogenesis in seminiferous tubules and correlation with ploidy, centrosome aberrations and STK15 level
The immunohistologically stained sections and those used for FISH, containing the seminiferous tubules, were evaluated with the DAPI-filter for the presence of different stages of spermatogenesis from spermatogonia to spermatozoa. These were analysed for alkaline phosphatase enzymatic reactivity, centrin, STK15 and the centromeres of chromosomes 12 and 15, respectively. The following 'centrin-score' was ascribed to tumors as a whole and to individual tubules: '1': the present germ cells had normal centrosomes composed of two centrioles; '2': four to eight centrioles; '3': more than eight centrioles. STK15 was scored subjectively as absent/weak ('1'), moderate ('2') or strong ('3'). A Johnson score (assessment of the quality of spermatogenesis based on number and furthest maturation stage present with a score of '10' being optimal with normal numbers of spermatozoa present, and a score of '1' representing total absence of germ cells and Sertoli cells) was attributed to individual tubules. Germ cells within seminiferous tubules were considered aneuploid when the number of signals for centromeres 12 and 15 were not 1/1 or 2/2. A total of 10 randomly selected cells per tubule were assessed in 10 tubules per case. The number of aneuploid cells was correlated with centrosome abnormalities or STK15 protein level in 10 randomly selected tubules per section.
Statistical analysis
A possible correlation between the number of aneuploid cells and the Johnson score was tested in parenchyma samples of four cases within a TGCT or CIS by ANOVA. A correlation between mean Johnson score and mean centrin score, and between mean Johnson score and mean BTAK score was tested in the parenchyma in patients with (n ¼ 13) and without (n ¼ 9) invasive seminoma/nonseminoma/CIS.
Results
We investigated whether aneuploidy of human TGCTs correlates with the presence of centrosome anomalies. Therefore, a series of seven germ cell tumors of newborn and infants (six teratomas and one yolk sac tumor), 26 invasive TGCTs (11 seminomas and 15 nonseminomas), 13 testis samples containing CIS and three spermatocytic seminomas were investigated by immunohistochemistry and FISH. The ploidy of these tumors has been reported before, showing that all TGCTs, including CIS, as well as the only yolk sac tumor of infants are aneuploid, and that the teratomas of newborn and infants are diploid (Rosenberg et al., 1998 (Rosenberg et al., , 1999 Looijenga et al., 2000) (Table 2 ). In addition, the spermatocytic seminomas contain diploid, tetraploid and hypertetraploid cells Rosenberg et al., 1998) . The number and conformation of the centrosomes in these tumors was determined using two different antibodies (directed against centrin and pericentrin), which revealed identical results.
Centrosome organization and STK15 protein in CIS, seminomas and nonseminomas All seminomas and nonseminomas showed an increased number of centrosomes per cell compared to normal cells. Their numbers per tumor cell varied between four and approximately 20, and they were arranged as aggregates at one pole of the nucleus (Figure 1a) . Within a single tumor, the pattern was homogeneously distributed, even in case of nonseminomas with different histological elements, including the fully differentiated, but aneuploid teratoma (Figure 1b) (Looijenga et al., 1991) . No differences in ploidy status, as demonstrated by the copy numbers of two reference chromosomes (Rosenberg et al., 1997 (Rosenberg et al., , 1999 , were found in three seminomas with the lowest level of centrosome-amplification (about four centrioles per cell) compared to three seminomas with the highest level of amplification (up to 20 centrioles per cell) by ANOVA (mean number of chromosome 12 signals per cell 3.2 versus 2.5, P ¼ 0.24; mean number of chromosome 15 signals per cell 2.3 versus 2.5, P ¼ 6.4). Immunohistochemistry showed that the STK15 protein was either absent or present at a very low level in TGCTs (see Figure 1a and b). In addition, none of the tumors showed amplification of the STK15 gene as studied by FISH (data not shown).
CIS cells were identified by the direct alkaline phosphatase staining in the testicular parenchyma adjacent to three seminomas and 10 nonseminomas. Double immunohistochemistry for alkaline phosphatase and centrin demonstrated the presence of amplified centrosomes in all CIS cells (see Figure 1c) . This is in agreement with their known aneuploid DNA content (De Graaff et al., 1992; Looijenga et al., 1993 Looijenga et al., , 2000 Gillis et al., 1994; Van Echten-Arends et al., 1995; Faulkner et al., 2000; Summersgill et al., 2001) , confirmed by FISH in the specific cases studied here (data not shown). The pattern of centrosome amplification in the CIS cells was more heterogeneous than observed in the matched invasive tumor. Similarly as in the invasive TGCTs, no or a very weak staining for STK15 was found. These results indicate that overall the pattern of centrosome organization and presence of STK15 in CIS cells is similar to the invasive components.
Infantile germ cell tumors and spermatocytic seminoma of the elderly
The only infantile yolk sac tumor studied (aneuploid), as well as two out of the six diploid teratomas of this age group showed amplification of the centrosome in about 20% of the tumor cells (see Figure 1e ). These cells were spread throughout the whole histological section analysed. The remaining four teratomas showed normal centrosomes, both in number and organization, in agreement with their diploid DNA content (Figure 1d ). Three of these teratomas and the one yolk sac tumors showed no or a weak staining for STK15 protein, while the remaining teratomas showed a strong staining in the tumor cells. Only one of these positive teratomas contained centrosome amplification (see above). All spermatocytic seminomas showed a percentage of the tumor cells with normal centrosome organization (about 40%), whereas the remaining cells had mostly four or eight centrosomes (see Figure 1f) . As controls, a number of diploid tumors of different origin (Leydig cell tumors and lymphomas) were included, which all showed a normal pattern of centrosome organization (data not shown).
Ploidy, centrosomes and STK15 status in relation to quality of spermatogenesis Testicular parenchyma samples of 13 patients with TGCTs (also containing CIS), and of nine patients with unrelated disorders were included in the analysis of the relation between centrosome organization and atrophy of the seminiferous tubules. Spermatogenesis was rated by means of the Johnson score for 10 individual tubules per case, on which ploidy, centrosome aberrations and the presence of STK15 protein were assessed. The quality of spermatogenesis was in general reduced in samples of patients with a TGCT compared to the other samples (median Johnson score of 6 compared to a median score of 8, with a range of 3-9 and 6-9, respectively). In the individual patients, the Johnson score of different tubules varied considerably, with occasional tubules showing marked deterioration also in case of an overall well-preserved spermatogenesis. In the individual seminiferous tubules, a clear correlation between impaired spermatogenesis and centrosome amplification was evident, regardless of the underlying disease and overall quality of spermatogenesis ( Figure  1g and h). This correlation was statistically significant (Po0.0001) (see Figure 2a) . In four samples derived from patients with non-TGCT-related disorders, we analysed the correlation between Johnson score and the number of aneuploid cells (Figure 2b ). Although in case of complete maturation to spermatozoa, the germ cells were diploid or haploid, tubules with disrupted maturation arrested at earlier stages contained significantly more aneuploid cells. The latter showed a more intense staining for STK15. This was also found in the normal germ cells of seminiferous tubules containing CIS.
Discussion
Our data show a correlation between the presence of amplified centrosomes and aneuploid DNA content for human TGCTs. Even though aneuploidy is the most frequent gross genomic aberration in solid tumors (Mitelman, 2000) , a similar correlation has only been described for a limited number of entities (Lingle et al., 1998 (Lingle et al., , 2002 Weber et al., 1998; Ghadimi et al., 2000; Gustafson et al., 2000; Kuo et al., 2000; Pihan et al., 2001 ). Since we observed no difference in ploidy status Centrosome abnormalities in germ cell tumors F Mayer et al of tumors with on average four or 20 centrosomes, the presence of amplified centrosomes per se and not their actual number seems to be of major importance for the aneuploidy of seminomas and nonseminomas. However, the number of cases investigated in this regard is too small to exclude small differences in ploidy depending on the number of centrioles present. It is of interest to note that these aberrations of centrosomes are already present in the preinvasive stage of TGCTs, in accordance with its aneuploidy (De Graaff et al., 1992) . This indicates that centrosomal changes do not represent a late stage of progression in TGCTs. In this regard, TGCTs differ from other solid tumors like prostate cancer, in which the level of centrosome anomalies correlate with Gleason score (Pihan et al., 2001) . The more heterogeneous pattern of centrosome amplification in CIS compared to the adjacent invasive tumor could be explained by a selective outgrowth of a certain clone of CIS cells during progression to an invasive tumor. Our data also show that centrosomal aberrations in TGCTs are not related to amplification and/or overexpression of the STK15 gene, as found in some types of aneuploid tumors (Zhou et al., 1998; Miyoshi et al., 2001) . It may, therefore, be that additional genes regulating chromosome segregation contribute towards induction of aneuploidy in TGCT. Two recently identified mammalian members of the STK15 kinase family, AuroraB (also referred to as Aurora1/Aik2) and AuroraC (also referred to as Aik3), have been reported to be overexpressed in several human cancers (Tatsuka et al., 1998; Katayama et al., 1999; Kimura et al., 1999) . However, it cannot be ruled out that overexpression of STK15 is involved in the initial obtainment of supernumerous centrosomes in TGCTs. In addition, it remains to be investigated whether dysregulation of the TGF beta pathway (Glick et al., 1999) is involved in the initial aneuploidization of TGCTs. A role of inactivation of P53, as indicated recently for breast (Meraldi et al., 2002) and prostate cancer (Ouyang et al., 2001) , seems unlikely in TGCTs because of the presence of the wild-type protein in almost all tumors (Kersemaekers et al., 2002 , and references cited therein). The correlation between ploidy and centrosome status in human TGCTs is not restricted to the seminomas and nonseminomas as demonstrated by the findings in the yolk sac tumor and teratomas of the infantile testis, which have a separate pathogenesis compared to TGCTs (for review, see Looijenga and Oosterhuis, 1999) . The aneuploid yolk sac tumor has amplified centrosomes in some of the tumor cells. The only tumors showing a normal centrosome organization are the diploid teratomas of the newborn and infants, and to a certain extent the spermatocytic seminomas. The finding of infantile teratomas containing a small cell fraction with amplified centrosomes remains unclear. It is conceivable that aneuploidy of the respective cells has been overlooked because of the techniques used for assessing their ploidy status. Besides the presence of diploid tumor cells, spermatocytic seminomas also contain tumor cells with a polyploid DNA content. Therefore, the subset of tumor cells containing four or eight centrosomes could be considered as 'normal' assuming a polyploid chromosome content. The infantile teratomas and the spermatocytic seminomas are the least malignant subtypes of germ cell tumors, although the teratomas may progress to the (aneuploid) malignant yolk sac tumor and the spermatocytic seminomas to sarcoma (Floyd et al., 1988; True et al., 1988; Matoska and Talerman, 1990; Burke and Mostofi, 1993) . Therefore, the data presented are in accordance with the model that aneuploidy and centrosome amplification are related to and may be a prerequisite for a more malignant phenotype. The presence of STK15 despite normal centrosomes in some of these infantile teratomas remains unexplained so far. Different localizations of STK15 have been described depending on the model investigated. In contrast to the centrosomal localization in HeLa cells in vitro, a cytoplasmic staining was seen in paraffin-embedded tissue samples from patients suffering from bladder cancer after antigen retrieval using the same antibody (Zhou et al., 1998; Sen et al., 2002) . In the fresh-frozen tissue sections of testis tissue and GCTs, the antibody resulted in a circumscript nuclear/perinuclear staining in cells in interphase. Whether these differences have a functional meaning or might just be caused by different experimental conditions remains to be elucidated.
Aneuploidy of germ cells is not confined to the situation after malignant transformation. It has also been found in semen of patients with a disturbed fertility (Lahdetie et al., 1997; Acar et al., 2000; Shi and Martin, 2000; Van Dyk et al., 2000) , both after acute external hazards, like chemotherapy, and primary infertility, the latter condition being a known risk factor for development of a TGCT (Moller and Skakkebaek 1999; Jacobsen et al., 2000a, b) . To investigate whether amplification of centrosomes also plays a role in the generation of aneuploid germ cells under nonmalignant conditions, we assessed spermatogenesis quality (by the Johnson score) in relation to ploidy, centrosome organization, and presence of STK15 protein. All samples showed a correlation between the presence of aneuploidy, centrosome number, and a poor Johnson score. The data also indicate that detection of supernumerous centrosomes and aneuploidy cannot be used as markers for CIS in semen. Of interest is that STK15 protein staining was stronger in germ cells of seminiferous tubules with a low Johnson score compared to seminiferous tubules with a high Johnson score as well as the TGCTs and CIS. This might be related to the model that spermatogonia respond to external stress factors by induction of STK15, which results in surplus numbers of centrosomes and subsequently aneuploidy of germ cells. Subsequently, this could lead to a differentiation block of the germ cells and atrophy. This idea is supported by the uniform picture in the testis of patients suffering from primary TGCTs and unrelated disorders including acute trauma. Another supporting argument is the finding of aneuploidy in oligospermic semen after chemotherapy for various malignancies (Robbins et al., 1997) . A similar course of events when occurring in primordial germ cells or gonocytes in the embryonic testis may initiate TGCTs. Role of STK15 in the initiation of centrosome amplification and induction of aneuploidy, as suggested, seems plausible in view of the recent reports that abnormal elevated expression of this protein is detected in a minor fraction of aneuploid bladder epithelial cells of near-diploid human bladder tumors (Sen et al., 2002) and also as an early event in rat mammary carcinogenesis (Goepfert et al., 2002) .
In conclusion, human TGCTs, that is, seminomas and nonseminomas of the adult testis, as well as teratomas and yolk sac tumors of newborn and infants, and spermatocytic seminoma of the elderly demonstrate a close relation between aneuploidy and amplification of centrosomes. As this feature is already present in CIS of the testis, it is an early event in development of TGCTs and not related to invasiveness. Although generation of centrosome aberrations in these tumors seems to be unrelated to STK15, this protein might be involved in the formation of aneuploid germ cells in case of a disturbed spermatogenesis.
